期刊文献+

妊娠足月产前发热的相关因素及对分娩结局的影响分析 被引量:1

Analysis of the related factors of prenatal fever in full-term pregnancy and its influence on delivery outcome
下载PDF
导出
摘要 目的分析妊娠足月产前发热的相关因素及对分娩结局的影响。方法选取80例妊娠足月分娩产妇作为研究对象,将产前监测体温>37.5℃的40例产妇纳入发热组,将体温正常的40例产妇纳入未发热组。分析影响产前发热的影响因素,并对发热产妇进行对症治疗,对比发热组产妇与未发热组产妇的分娩结局。结果两组年龄、保胎史、妊娠期糖尿病比较,差异无统计学意义(P>0.05);发热组产次为1次、呼吸道疾病、生殖道感染、羊水污染、缩宫素使用及前列素制剂使用产妇占比均高于未发热组,差异有统计学意义(P<0.05)。经Logistic回归分析,初产妇、呼吸道疾病、生殖道感染、羊水污染、缩宫素使用、前列素制剂使用是产前发热的影响因素(P<0.05)。发热组剖宫产发生率75.00%、产后出血发生率30.00%、新生儿窒息发生率17.50%均高于未发热组的35.00%、7.50%、2.50%,差异有统计学意义(P<0.05)。结论初产妇、呼吸道疾病、生殖道感染、羊水污染、缩宫素使用、前列素制剂使用均为产妇产前发热的影响因素,对产妇做到早发现、早治疗,积极治疗原发病,预防感染,严格控制缩宫素用量,对于应用前列腺素制剂的产妇进行严密监测,以减少不良结局的发生。 Objective To analyze the related factors of prenatal fever in full-term pregnancy and its influence on delivery outcome.Methods 80 cases of full-term pregnant women were selected as the research subjects.40 cases of maternal body temperature>37.5℃were included in the fever group,and 40 cases of normal body temperature were included in the non-fever group.The influencing factors affecting prenatal fever were analyzed,and symptomatic treatment was given to febrile women,and the delivery outcomes of fever group and non-fever group were compared.Results There was no statistically significant difference in age,history of fetal protection and gestational diabetes mellitus between the two groups(P>0.05).The proportion of patients with 1 birth,respiratory disease,reproductive tract infection,amniotic fluid pollution,oxytocin use and prostaglandin preparations in the fever group were higher than those in the non-fever group,and the difference was statistically significant(P<0.05).Logistic regression analysis showed that primipara,respiratory disease,reproductive tract infection,amniotic fluid pollution,oxytocin use,prostaglandin use were influencing factors of prenatal fever(P<0.05).The incidence of cesarean section,postpartum hemorrhage and neonatal asphyxia in fever group were 75.00%,30.00%and 17.50%respectively,which were higher than 35.00%,7.50%and 2.50%in non-fever group,and the difference was statistically significant(P<0.05).Conclusion Primipara,respiratory disease,reproductive tract infection,amniotic fluid pollution,oxytocin use,prostaglandin preparation use are influencing factors of maternal prenatal fever.Early detection and early treatment of parturients,active treatment of the primary disease,prevention of infection,strict control of oxytocin dosage,and strict monitoring of parturients using prostaglandin preparations can reduce the occurrence of adverse outcomes.
作者 王佳斌 刘群 赵斌 WANG Jia-bin;LIU Qun;ZHAO bin(Shenyang Women’s and Children’s Hospital,Shenyang 110014,China)
机构地区 沈阳市妇婴医院
出处 《中国现代药物应用》 2020年第23期17-19,共3页 Chinese Journal of Modern Drug Application
关键词 妊娠足月 产前发热 影响因素 Full-term pregnancy Prenatal fever Influencing factors
  • 相关文献

参考文献11

二级参考文献67

  • 1刘杰.浅析妊娠足月产前发热的相关影响因素及治疗方法[J].求医问药(下半月),2013(11):73-74. 被引量:1
  • 2肖荣冬,翁国星,韩涛,谢维泉,陈同,谢琦.81例感染性心内膜炎的病原学分析[J].中国医药,2006,1(1):7-8. 被引量:11
  • 3王旭红,沈月华,黄咏梅,施婴婴,丁善雯,刘志伟,唐征,黄小艺,张鑫瑜,周静,魏晏,夏璟,汤国英,姚明珠,虞敏毓.上海市母产前发热与早期新生儿败血症临床多中心研究[J].中华围产医学杂志,2006,9(4):262-265. 被引量:15
  • 4谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 5Klemetti R, Che X, Gao Y, et al.Cesarean section delivery among primiparous women in rural China: an emerging epidemic[J]. American Journal of Obstetrics and Gynecology, 2010, 202(1): 1111-1115.
  • 6Stjernholm Y V, Petersson K, Eneroth E.Changed indications for cesarean sections[J].Acta Obstetricia et Gynecologica, 2010, 89(1): 879-880.
  • 7Vineelj J, Sokol I, Pevec D, et al. Infective endocarditis of aortic valve during pregnancy: a case report[J]. Inter J Cardiol, 2008,126(1): e10-e12.
  • 8Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis[J]. Rev Esp Cardiol (Engl Ed), 2016,69(1):69.
  • 9Nakatani S, Mitsutake K, Hozumi T, et al. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001[J]. Circ J, 2003,67(11): 901-905.
  • 10To K, Miyake N, Nagasaki Y, et al. Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA[J]. Jpn J Antibiot, 2011,64(6): 389-394.

共引文献88

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部